Biggest News Aggregation in the World
📰 Alpn News

Alpn News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alpn. Real-time updates on events, politics, business and more.

Alpine Immune Sciences (NASDAQ:ALPN) Trading Down 5.6%

Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) traded down 5.6% on Wednesday . The company traded as low as $36.80 and last traded at $37.02. 583,722 shares were traded during trading, a decline of 48% from the average session volume of 1,126,938 shares. The stock had previously closed at $39.21. Analyst […]
Franklin Resources Inc Alpine Immune Sciences Alpine Immune Sciences Inc Blackrock Inc Alpine Immune Sciences Trading Down Morgan Stanley

Brokerages Set Alpine Immune Sciences, Inc. (NASDAQ:ALPN) PT at $38.86

Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) have earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12-month target price among brokerages that have covered the stock in the […]
Morgan Stanley Schonfeld Strategic Advisors Analyst Recommendations For Alpine Immune Sciences Alpine Immune Sciences Inc Alpine Immune Sciences Stock Down News Ratings For Alpine Immune Sciences Daily

Wolfe Research Initiates Coverage on Alpine Immune Sciences (NASDAQ:ALPN)

Wolfe Research started coverage on shares of Alpine Immune Sciences (NASDAQ:ALPN – Free Report) in a report released on Thursday, MarketBeat.com reports. The brokerage issued an outperform rating and a $44.00 target price on the biotechnology company’s stock. Other analysts have also recently issued reports about the stock. Royal Bank of Canada lifted their target […]
United States Petera Thompson Alpine Immune Sciences Inc Securities Exchange Commission Wolfe Research Alpine Immune Sciences Stock Performance

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Wolfe Research Initiates Coverage on Alpine Immune Sciences (NASDAQ:ALPN)

Research analysts at Wolfe Research initiated coverage on shares of Alpine Immune Sciences (NASDAQ:ALPN – Get Free Report) in a report released on Thursday, Briefing.com reports. The firm set an “outperform” rating and a $44.00 price target on the biotechnology company’s stock. Wolfe Research’s price target points to a potential upside of 51.05% from the […]
United States James Paul Rickey Morgan Stanley Securities Exchange Commission Capital Management Alpine Immune Sciences Inc

Alpine Immune Sciences (NASDAQ:ALPN) Trading Down 4%

Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s share price traded down 4% during trading on Tuesday . The stock traded as low as $26.34 and last traded at $26.34. 347,216 shares changed hands during trading, a decline of 65% from the average session volume of 991,954 shares. The stock had previously closed at […]
Nova Scotia Petera Thompson Berenberg Bank Royal Bank Vanguard Group Inc Morgan Stanley

Short Interest in Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Grows By 32.7%

Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 3,980,000 shares, an increase of 32.7% from the December 15th total of 3,000,000 shares. Based on an average daily volume of 788,500 shares, the short-interest […]
New Zealand General New Zealand James Paul Rickey Alpine Immune Sciences Company Profile Securities Exchange Commission Morgan Stanley
Source: wkrb13.com

Alpine Immune Sciences (NASDAQ:ALPN) Trading Up 3.8%

Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) were up 3.8% during trading on Wednesday . The stock traded as high as $20.31 and last traded at $20.25. Approximately 255,066 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 425,013 shares. The stock had previously […]
United States James Paul Rickey Alpine Immune Sciences Price Performance Securities Exchange Commission News Ratings For Alpine Immune Sciences Daily Morgan Stanley

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Receives Average Rating of "Buy" from Brokerages

Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) has earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have issued a report on the stock in […]
Nova Scotia James Paul Rickey Alpine Immune Sciences Inc Morgan Stanley Geode Capital Management Alpine Immune Sciences

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science